A rational approach to home oxygen use in infants and children

Paediatric Respiratory Reviews

Volumn 7, Issue 3, 2006, Pages 215-222

  MacLean, Joanna E ^a   Fitzgerald, Dominic A ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

clinical recommendations; evidence based medicine; home oxygen; outcome measures; oxygen targets

Indexed keywords

OXYGEN;

AIRWAY OBSTRUCTION; ARTERIAL OXYGEN SATURATION; CARDIOLOGIST; CHILD; CHRONIC LUNG DISEASE; CHRONIC RESPIRATORY FAILURE; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG INDICATION; EVIDENCE BASED MEDICINE; FOLLOW UP; HOME CARE; HOSPITAL DISCHARGE; HUMAN; HYPERCAPNIA; HYPOXEMIA; INFANT; INTERSTITIAL LUNG DISEASE; MEDICAL SPECIALIST; NEONATOLOGY; NEWBORN DISEASE; OUTCOMES RESEARCH; OXYGEN THERAPY; PALLIATIVE THERAPY; PATIENT MONITORING; PEDIATRICIAN; PRESCRIPTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS;

ANOXEMIA; ANOXIA; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; HOME CARE SERVICES; HOME NURSING; HUMANS; INFANT; INFANT, NEWBORN; LUNG DISEASES; OXYGEN; OXYGEN INHALATION THERAPY;

EID: 33748056839     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2006.04.006     Document Type: Review

References (77)

1. Levine B.E., Bigelow D.B., Hamstra R.D., et al. The role of long-term continuous oxygen administration in patients with chronic airway obstruction with hypoxaemia. Ann Intern Med 66 (1967) 639-650
2. Noctural Oxygen Therapy Trial Group - Continuous or nocturnal oxygen therapy in hypoxaemic chronic obsturtive lung disease. Ann Intern Med 93 (1980) 391-398
3. Swinburn C.R., Mould H., Stone T.N., et al. Symptomatic benefit of supplemental oxygen in hypoxemic patients with Chronic Lung Disease. Am Rev Respir Dis 143 (1991) 913-915
4. Pinney M.A., and Cotton E.K. Home management of bronchopulmonary dysplasia. Pediatrics 58 (1976) 856-859
5. Norzila M.Z., Azizi B.H.O., Norrashidah A.W., et al. Home oxygen therapy for children with chronic lung disease. Med J Malaysia 56 (2001) 151-157
6. Guyatt G.H., McKin D.A., Austin P., et al. Appropriateness of domiciliary oxygen delivery. Chest 118 (2000) 1303-1308
7. Strom K., and Boe J. A national register for long-term oxygen therapy in chronic hypoxia: preliminary results. Eur Respir J 1 (1988) 952-958
8. Northway W.H., Rosan R.C., and Porter D.Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. NEJM 276 (1967) 357-368
9. O'Brodovich H.M., and Mellins R.B. Bronchopulmonary dysplasia. Unresolved neonatal acute lung injury. Am Rev Respir Dis 132 (1985) 694-709
10. Shennan A.T., Dunn M., Ohlsson A., et al. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirements in the neonatal period. Pediatrics 82 (1988) 527-532
11. ATS Documents. Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med 168 (2003) 356-396
12. Davis P.G., Thorpe K., Roberts R., et al. The Trial of Indomethacin Prophylaxis in Preterms (TIPP) Investigators. Evaluating "old" definitions for the "new" bronchopulmonary dysplasia. J Pediatr 140 (2002) 555-560
13. Jobe A.H., and Bancalari E. Bronchopulmonary Dysplasia. Am J Respir Crit Care Med 163 (2001) 1723-1729
14. Jobe A.J. The new BPD: an arrest of lung development. Pediatr Res 46 (1999) 641-643
15. Coalson J.J. Pathology of new bronchopulmonary dysplasia. Semin Neonatol 8 (2003) 73-81
16. Ambalavanan N., and Carlo W.A. Bronchopulmonary dysplasia: new insights. Clin Perinatol 31 (2004) 613-628
17. Bourbon J., Boucherat O., Chailley-Heu B., and Delacourt C. Control mechanism of lung alveolar development and their disorders in bronchopulmonary dysplasia. Pediatr Res 57 (2005) 38R-46R
18. Fitzgerald D.A., Mesiano G., Brosseau L., and Davis G.M. Pulmonary outcomes in extremely low birth weight infants. Pediatrics 105 (2000) 1209-1215
19. Lemons J.A., Bauer C.R., Oh W., et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. Pediatrics 107 (2001) E1
20. Van Marter L.J., Allred E.N., Pagano M., et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics 105 (2000) 1194-1201
21. Walsh M.C., Yao Q., Gettner P., et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 114 (2004) 1305-1311
22. Smith V.C., Zupancic J.A., McCormick M.C., et al. Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002. J Pediatr 146 (2005) 469-473
23. Sauve R.S., McMillan D.D., Mitchell I., et al. Home oxygen therapy. Outcome of infants discharged from NICU on continuous treatment. Clin Pediatr 28 (1989) 113-118
24. Hudak B.B., Allen M.R., Hudak M.L., and Loughlin G.M. Home oxygen therapy for chronic lung disease in extremely low-birth weight infants. AJDC 143 (1989) 357-360
25. Askie L.M., Henderson-Smart D.J., Irwig L., and Simpson J.M. Oxygen-saturation targets and outcomes in extremely preterm infants. NEJM 349 (2003) 959-967
26. Victor S., and Shaw B. Carbon dioxide levels do not predict duration of home oxygen requirement: a retrospective study. J Perinat Med 30 (2002) 333-335
27. Northway W.H., Moss R.B., Carlisle K.B., et al. Late pulmonary sequelae of bronchopulmonary dysplasia. NEJM 323 (1990) 1793-1799
28. Kennedy J.D., Edward L.J., Bates D.J., et al. Effects of birthweight and oxygen supplementation on lung function in late childhood in children of very low birth weight. Pediatr Pulmonol 30 (2000) 32-40
29. Hacking D., Smyth R., Shaw N., et al. Idiopathic pulmonary fibrosis in infants: good prognosis with conservative management. Arch Dis Child 83 (2000) 152-157
30. Roberts D.H., Lepore J.J., Maroo A., et al. Oxygen therapy improves cardiac index and pulmonary vascular resistance in patients with pulmonary hypertension. Chest 120 (2001) 1547-1555
31. Ohashi N., Matsushima M., Maeda M., and Yamaki S. Advantages of oxygen inhalation therapy for postoperative pulmonary hypertension. Pediatr Cardiol 26 (2005) 90-92
32. Selvadurai H., and Fitzgerald D.A. Measuring blood Oxygen. Recent Advances in Paediatrics (2000), Churchill Livingston, London, UK 18
33. Mendeloff E.N., Meyers B.F., Sundt T.M., et al. Lung transplantation for pulmonary vascular disease. Ann Thorac Surg 73 (2002) 209-217
34. Buyse B., Meersseman W., and Demedts M. Treatment of chronic respiratory failure in kyphoscoliosis: oxygen or ventilation?. Eur Respir J 22 (2003) 525-528
35. Beebe D.W., Wells C.T., Jeffries J., et al. Neuropsychological effects of pediatric obstructive sleep apnea. J Int Neuropsychol Soc 10 (2004) 962-975
36. Booth S., Anderson H., Swannick M., et al. The use of oxygen in the palliation of breathlessness. A report of the expert working group of the scientific committee of the association of palliative medicine. Respir Med 98 (2004) 66-77
37. Crockett AJ, Cranston JM, Moss JR, Alpers JH. Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005; (4):CD001744.
38. Crockett, AJ, Cranston, JM, Antic, N. Domiciliary oxygen for interstitial lung disease. Cochrane Database Syst Rev 2001; (3): CD002883.
39. Goodman G., Perkin R., Anas N.G., et al. Pulmonary hypertension in infants with bronchopulmonary dysplasia. J Pediatr 112 (1988) 67-72
40. Gill A.B., and Weindling A.M. Raised pulmonary artery pressure in very low birthweight infants requiring supplemental oxygen at 36 weeks after conception. Arch Dis Child 72 (1995) F20-F22
41. Zinman R., Corey M., Coates A.L., et al. Nocturnal home oxygen in the treatment of hypoxemic cystic fibrosis patients. J Pediatr 114 (1989) 368-377
42. Donn S. Cost effectiveness of home management of bronchopulmonary dysplasia. Pediatrics 70 (1982) 330-331
43. Silva D.T., Hagan R., and Sly P.D. Home oxygen management of neonatal chronic lung disease in Western Australia. J Paediatr Child Health 31 (1995) 185-188
44. Baraldi E., Carra S., Vencato F., et al. Home oxygen therapy in infants with bronchopulmonary dysplasia: a prospective study. Eur J Pediatr 156 (1997) 878-882
45. Greenough A., Alexander J., Burgess S., et al. Home oxygen status and rehospitalisation and primary care requirements of infants with chronic lung disease. Arch Dis Child 86 (2002) 40-43
46. McAleese K.A., Knapp M.A., and Rhodes T.T. Financial and emotional cost of bronchopulmonary dysplasia. Clin Pediatr 32 (1993) 393-400
47. 2 in chronic neonatal lung disease: does it improve sleep. Pediatr Pulmonol 26 (1998) 235-240
48. Abman S.H., Accurso F.J., and Koops B.L. Experience with home oxygen in the management of infants with bronchopulmonary dysplasia. Clin Pediatr 23 (1984) 471-476
49. Abman S.H., Wolfe R.R., Accurso F.J., et al. Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia. Pediatrics 75 (1985) 80-84
50. Alpert B.E., Gainey M.A., Schidlow D.V., and Capitanio M.A. Effect of oxygen on right ventricular performance evaluated by radionuclide angiography in two young patients with chronic lung disease. Pediatr Pulmonol 3 (1987) 149-152
51. Fitzgerald D.A., Evans N., Van Asperen P.P., and Henderson-Smart D. Subclinical persisting pulmonary hypertension in chronic neonatal lung disease. Arch Dis Child 70 (1994) F118-F122
52. Bass J.L., Corwin M., Gozal D., et al. The effect of chronic or intermittent hypoxia on cognition in childhood: a review of the evidence. Pediatrics 114 (2004) 805-816
53. Harris M.A., and Sullivan C.E. Sleep pattern and supplementary oxygen requirements in infants with chronic neonatal lung disease. Lancet 345 (1995) 831-832
54. Groothius J.R., and Rosenberg A.A. Home oxygen promotes weight gain in infants with bronchopulmonary dysplasia. Am J Dis Child 141 (1987) 992-995
55. Moyer-Mileur L.J., Nielson D.W., Pfeffer K.D., et al. Eliminating sleep-associated hypoxaemia improves growth in infants with bronchopulmonary dysplasia. Pediatrics 98 (1996) 779-783
56. Fitzgerald D.A., Van Asperen P.P., Feddema P., et al. Sleep, respiratory rate and growth hormone in chronic neonatal lung disease. Pediatr Pulmonol 26 (1998) 241-249
57. Shah A.R., Keens T.G., and Gozal D. Effect of supplemental oxygen on supramaximal exercise performance and recovery in cystic fibrosis. J Appl Physiol 83 (1997) 1641-1647
58. Spier S., Rivlin J., Hughes D., and Levinson H. The effect of oxygen on sleep, blood gases, and ventilation in Cystic Fibrosis. Am Rev Respir Dis 129 (1984) 712-718
59. Gozal D. Nocturnal ventilatory support in patients with cystic fibrosis: comparison with supplemental oxygen. Eur Respir J 10 (1997) 1999-2003
60. Milross M.A., Piper A.J., Norman M., et al. Low-flow oxygen and bilevel ventilatory support. Effects on ventilation during sleep in children with Cystic Fibrosis. Am J Respir Crit Care Med 163 (2001) 129-134
61. Weinberger B., Laskin D.L., Heck D.E., and Laskin J.D. Oxygen toxicity in premature infants. Toxicol Appl Pharmacol 181 (2002) 60-67
62. Finer N.N., Bates R., and Tomat P. Low flow oxygen delivery via nasal cannula to neonates. Pediatr Pulmonol 21 (1996) 48-51
63. The STOP-ROP Multicenter Study Group. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), A randomized, controlled trial. I: Primary outcomes. Pediatrics 105 (2000) 295-310
64. Katz-Salamon M., and Lagercrantz H. Hyoxic ventilatory defence in very preterm infants: attentuation after long term oxygen treatment. Arch Dis Child 74 (1994) F90-F95
65. Guenard H., Verhas M., Todd-Prokopek A., et al. Effects of oxygen breathing on regional distribution of ventilation and perfusion in hypoxemic patients with Chronic Lung Disease. Am Rev Respir Dis 125 (1982) 12-17
66. Hazinski T.A., Hansen T.N., Sion J.A., and Tooley W.H. Effect of oxygen administration during sleep on skin surface oxygen and carbdon dioxide tensions in patients with chronic lung disease. Pediatrics 67 (1981) 626-630
67. Benditt J.O. Adverse effects of low-flow oxygen therapy. Respir Care 45 (2000) 54-61
68. Kopelman A.E. Airway obstruction in two extremely low birthweight infants treated with oxygen cannulas. J Perinatol 23 (2003) 164-165
69. Robb B.W., Hungness E.S., Hershko D.D., et al. Home oxygen therapy: adjunct or risk factor?. J Burn Care Rehabil 24 (2003) 403-406
70. Hunt C.E., Corwin M.J., Lister G., et al. Longitudinal assessment of hemoglobin oxygen saturation in healthy infants during the first 6 months of age. J Pediatr 134 (1999) 580-586
71. Samuels M.P. The effects of flight and altitude. Arch Dis Child 89 (2004) 448-455
72. Ellsbury D.L., Acarregue M.J., McGuinness G.A., et al. Controversy surrounding the use of home oxygen for premature infants with bronchopulmonary dysplasia. J Perinatol 24 (2004) 36-40
73. Solis A., Harrison G., and Shaw B.N.J. Assessing oxygen requirement after discharge in chronic lung disease: a survey of current practice. Eur J Pediatr 161 (2002) 428-430
74. Askie LM, Henderson-Smart DJ. Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants. Cochrane Database Syst Rev 2001; (4):CD001077.
75. Bard H., Belanger S., and Fouron J.-C. Comparison of effects of 95% and 90% oxygen saturations in respiratory distress syndrome. Arch Dis Child 75 (1996) F94-F96
76. Tin W., Milligan D.W.A., Pennefather P., and Hey E. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed 84 (2001) F106-F110
77. Documents A.T.S. Standards for the diagnosis and care of patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 152 (1995) S77-S120